Bioqual (Bioqual) EPS (Basic) : $4.10 (TTM As of May. 2018)

View and export this data going back to . Start your Free Trial

What is Bioqual EPS (Basic)?

Bioqual's basic earnings per share (Basic EPS) for the six months ended in May. 2018 was $4.10. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in May. 2018 was $4.10.

Bioqual's EPS (Diluted) for the six months ended in May. 2018 was $4.10. Its EPS (Diluted) for the trailing twelve months (TTM) ended in May. 2018 was $4.10.

Bioqual's EPS without NRI for the six months ended in May. 2018 was $4.09. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in May. 2018 was 4.09.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

Bioqual EPS (Basic) Historical Data

The historical data trend for Bioqual's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioqual EPS (Basic) Chart

Bioqual Annual Data

Trend

May01

May03

May04

May05

May06

May07

May10

May11

May17

May18

EPS (Basic)

Get a 7-Day Free Trial

1.21

0.46

0.45

4.44

4.10

Bioqual Semi-Annual Data
	May96	May97	May98	May99	May00	May01	May03	May04	May05	May06	May07	May10	May11	May17	May18
EPS (Basic)	Get a 7-Day Free Trial										1.21	0.46	0.45	4.44	4.10

Bioqual EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Bioqual's Basic EPS for the fiscal year that ended in May. 2018 is calculated as

Basic EPS (A: May. 2018 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3.662	-	0)	/	0.893
	=	4.10

Bioqual's Basic EPS for the quarter that ended in May. 2018 is calculated as

Basic EPS (Q: May. 2018 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(3.662	-	0)	/	0.893
	=	4.10

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS (Basic) for the trailing twelve months (TTM) ended in May. 2018 was $4.10

Bioqual (OTCPK:BIOQ) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Bioqual EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Bioqual's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioqual (Bioqual) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Bioqual Inc (OTCPK:BIOQ) » Definitions » EPS (Basic)

Comparable Companies

STIM VNRX PSNL PRE MDXH ENZ TTOO BNR NOTV ACRS TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN

Traded in Other Exchanges

N/A

Address

9600 Medical Center Drive, Suite 101, Rockville, MD, USA, 20850

Website

https://www.bioqual.com

Bioqual Inc is a United States-based medical research company. It is engaged in providing contract research services focused on animal models of human diseases, including AIDS, influenza, RSV infection, flavivirus infections like Zika and Dengue, malaria, hepatitis, and cancer. The company is also involved in the evaluation of vaccines, vaccine therapeutics, microbicides, and drug therapies. It provides services to the federal government, universities, and the life science and pharmaceutical industries. It derives revenue from the provision of contract research services.

Executives

Williams Frank E Jr

other: Communication, See Remarks

2789-B HARTLAND ROAD, FALLS CHURCH VA 22043

Bioqual (Bioqual) Headlines

No Headlines